Consensus $35.78M. Sees FY23 gross margin 80%-83%.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CVRX:
- CVRx Reports First Quarter 2023 Financial and Operating Results
- CVRx management to meet with Lake Street
- CVRx to Report First Quarter 2023 Financial and Operating Results and Host Conference Call on April 27th, 2023
- CVRx presents data from post-market phase of BeAT-HF trial
- Totality of Evidence from BeAT-HF Study Shows CVRx’s Barostim Provides Long-term Benefits for Patients with Heart Failure